Our technology enables precise and comprehensive capturing of disease signatures with uniquely high sensitivity and multiplexing capability. We apply this breakthrough technology to PCR and sequencing workflows across a wide range of applications.
detection of mutations down to 0.1%
variant allele frequency
accurate quantification using
a simple workflow
covering most frequent
mutations
compatible with tissue and
plasma samples
NuProbe’s proprietary technologies enable highly sensitive detection and quantitation of mutations with a wide range of applications.
We are committed to advancing human health by bringing together cutting-edge innovations with leading scientific expertise and management.
Our technologies have been successfully applied in research and published in peer-reviewed articles.
NuProbe Announces Licensing Deal with Oxford Nanopore
AMP 2020 Annual Meeting & Expo
© 2020 NuProbe Global. All Rights Reserved
